Funding for this research was provided by:
Kerman University of Medical Sciences (97001007)
Received: 17 February 2020
Accepted: 28 August 2020
First Online: 1 September 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of Kerman University of Medical Sciences (KUMS) (Ethical code: IR.KMU.REC.1397.567). Ethical considerations were taken into account during data collection and analysis. Any questions asked from the participants were discussed in details, and informed verbal consent was obtained from the participants before recording the interviews. The participants were assured that their information will be maintained confidential, and no personal information will be identified in any publications arising from the study. Participants were informed that participation in the study was entirely voluntary and they could withdraw from the study at any time. Respondents’ names were removed from the transcribed documents during data analysis, and other identifiers (i.e. Patient, Food and Drug Administration inspector, Pharmacist, Insurance inspector, and Pharmaceutical Technician) were replaced in the quotations used.
: Not applicable.
: The authors declare that they have no competing interests.